Edwards Lifesciences Corp/ US28176E1082 /
| 08.11.2024 21:59:59 | Diff. +0,40 | Volumen | Geld- | Brief- | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 66,24USD | +0,61% | 132.547 Umsatz: 8,78 Mio. |
-Geld Vol: - | -Brief Vol: - | 39,06 Mrd.USD | - | 28,67 |
Aktiva
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 867,5000 | 1.060,3000 | 1.395,2000 | 1.546,6000 | 1.632,8000 | ||||||
| Immaterielle Vermögensgegenstände | 343,2000 | 336,5000 | 331,4000 | 323,6000 | 285,2000 | ||||||
| Finanzanlagen | 506,3000 | 585,5000 | 801,6000 | 1.834,2000 | 1.239 | ||||||
| Anlagevermögen | 3.036,8000 | 3.504,1000 | 4.146,1000 | 5.321,9000 | 5.196,7000 | ||||||
| Vorräte | 607 | 640,9000 | 802,3000 | 726,7000 | 875,5000 | ||||||
| Forderungen | 456,9000 | 543,6000 | 514,6000 | 582,2000 | 643 | ||||||
| Liquide Mitteln | 714,1000 | 1.179,1000 | 1.183,2000 | 862,8000 | 769 | ||||||
| Umlaufvermögen | 2.286,9000 | 2.984 | 3.091 | 3.180,7000 | 3.095,8000 | ||||||
| Aktiva, gesamt | 5.323,7000 | 6.488,1000 | 7.237,1000 | 8.502,6000 | 8.292,5000 | ||||||
Passiva
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 134 | 180,4000 | 196,5000 | 204,5000 | 201,9000 | ||||||
| Langfristige Schulden | 593,8000 | 594,4000 | 595 | 595,7000 | 596,3000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | - | - | - | - | - | ||||||
| Rückstellungen | 876,6000 | 696,5000 | 670,2000 | 802,3000 | - | ||||||
| Verbindlichkeiten | 2.183,3000 | 2.339,8000 | 2.662,8000 | 2.666,7000 | 2.485,8000 | ||||||
| Gezeichnetes Kapital | 645,6000 | 654,3000 | 636,4000 | 642 | 646,3000 | ||||||
| Eigenkapital | 3.140,4000 | 4.148,3000 | 4.574,3000 | 5.835,9000 | 5.806,7000 | ||||||
| Minderheitenanteile | - | - | - | - | - | ||||||
| Passiva, gesamt | 5.323,7000 | 6.488,1000 | 7.237,1000 | 8.502,6000 | 8.292,5000 | ||||||
Gewinn- und Verlustrechnung
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 3.722,8000 | 4.348 | 4.386,3000 | 5.232,5000 | 5.382,4000 | ||||||
| Abschreibungen (Gesamt) | - | - | - | - | - | ||||||
| Betriebsergebnis | 748,2000 | 1.146,8000 | 897,6000 | 1.690,3000 | 1.748,5000 | ||||||
| Zinsergebnis | -2,1000 | -11,5000 | -7,6000 | 1 | -16,3000 | ||||||
| Ergebnis vor Steuern | 761,4000 | 1.166,5000 | 916,7000 | 1.702 | 1.767,4000 | ||||||
| Ertragsteuern | 39,2000 | 119,6000 | 93,3000 | 198,9000 | 245,5000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | - | - | - | - | - | ||||||
| Konzernjahresüberschuss | 722,2000 | 1.046,9000 | 823,4000 | 1.503,1000 | 1.521,9000 | ||||||
Pro Aktie
Cash Flow
| 2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
2020 US GAAP in Mio. USD |
2021 US GAAP in Mio. USD |
2022 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 926,8000 | 1.179,4000 | 1.054,3000 | 1.732,1000 | 1.218,2000 | ||||||
| Cash Flow aus Investitionstätigkeit | 76,7000 | -595,8000 | -531,1000 | -1.722,5000 | 252,3000 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -1.101,2000 | -115,6000 | -486,9000 | -356,3000 | -1.584,5000 | ||||||
| Veränderung der liquiden Mittel | -104,2000 | 465 | 15,8000 | -332,8000 | -94,8000 | ||||||
| Anzahl der Mitarbeiter | 12.800 | 13.900 | 14.900 | 15.700 | - | ||||||
